F-18 FDG PET-CT fusion in radiotherapy treatment planning for head and neck cancer
- 16 March 2005
- journal article
- Published by Wiley in Head & Neck
- Vol. 27 (6), 494-502
- https://doi.org/10.1002/hed.20179
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Role of fusion in radiotherapy treatment planningSeminars in Nuclear Medicine, 2003
- Diagnostic and Prognostic Value of [18F]Fluorodeoxyglucose Positron Emission Tomography for Recurrent Head and Neck Squamous Cell CarcinomaJournal of Clinical Oncology, 2002
- Can positron emission tomography improve the quality of care for head-and-neck cancer patients?International Journal of Radiation Oncology*Biology*Physics, 2001
- Diagnosis and Staging of Head and Neck CancerJAMA Otolaryngology–Head & Neck Surgery, 2000
- Surveillance for Recurrent Head and Neck Cancer Using Positron Emission TomographyJournal of Clinical Oncology, 2000
- Lymph Node Detection of Head and Neck Squamous Cell Carcinomas by Positron Emission Tomography With Fluorodeoxyglucose F 18 in a Routine Clinical SettingJAMA Otolaryngology–Head & Neck Surgery, 1999
- Prospective comparison of 18 F-FDG PET with conventional imaging modalities (CT, MRI, US) in lymph node staging of head and neck cancerEuropean Journal of Nuclear Medicine and Molecular Imaging, 1998
- The contribution of 18F-fluoro-2-deoxy-glucose positron emission tomographic imaging to radiotherapy planning in lung cancer1Lung Cancer, 1998
- A prospective study of PET-FDG imaging for the assessment of head and neck squamous cell carcinomaClinical Otolaryngology, 1997
- A comparative diagnostic study of head and neck nodal metastases using positron emission tomographyThe Laryngoscope, 1995